Skip to main content
menu

Eva Galka, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-1611

Fax: (585) 273-1252

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Locations

UR Medicine Surgical Oncology
160 Sawgrass Dr
Suite 120
Rochester, NY 14620

Wilmot Cancer Institute
601 Elmwood Ave
Rochester, NY 14642

Faculty Appointments

Patient Care Settings

Cancer, Surgery

Biography

Professional Background

The University of Rochester Medical Center is pleased to announce the addition of Eva Galka, M.D. as an Assistant Professor of Surgery. Dr. Galka earned two Bachelor of Science degrees, with highest honors, in Ceramic Engineering and Biomedical Engineering & Applied Sciences from Rutgers University College of Engineering in New Brunswick, New Jersey. She received her medical degree from Dartmouth Medical School in Hanover, New Hampshire.
From 2000 through 2007, Dr. Galka completed her internship and residency in general surgery, as well as a two-year fellowship in surgical research, at Pennsylvania State University/Hershey Medical Center in Pennsylvania. Dr. Galka completed a Surgical Oncology Fellowship at the University of Chicago in Illinois. She is licensed to practice medicine in the states of New York and Illinois and is board certified by the American Board of Surgery.
Dr. Galka has been the recipient of numerous awards and grants including the John Waldhausen Fellowship Award for Research, the American Physiological Society Research Recognition Award for Outstanding Abstract Presentation, the American Society of Colon and Rectal Surgeons (ASCRS) Research Grant and the University of Chicago Breast Cancer SPORE Developmental Research Project Grant. She has authored a wide variety of publications and has given numerous presentations at national surgery meetings throughout the United States.
In addition to being a member of professional organizations including the Society of Surgical Oncology, American Society of Clinical Oncology, American College of Surgeons, Association of Academic Surgeons and American Association of Cancer Research, Dr. Galka has developed clinical trials such as "A Pilot Study of Chemoprevention of Green Tea (Polyphenon E) in Women with Ductal Carcinoma in Situ (DCIS)."
Dr. Galka's clinical interests include the management of hepato-pancreatico-biliary (pancreatic and hepatobiliary cancers) and gastrointestinal malignancies, melanoma and sarcoma. Her research interests include understanding the mechanisms of apoptosis (programmed cell death) and its relation to novel treatments for cancer.

Credentials

Specialties

    Education

    2000
    MD | Dartmouth Medical School

    Post-doctoral Training & Residency

    07/01/2007 - 06/30/2010
    Fellowship in Surgical Oncology at University of Chicago Hospitals

    07/01/2001 - 06/30/2007
    Residency in Surgery (General Surgery) at Penn State Milton S Hershey Medical Center

    07/01/2000 - 06/30/2001
    Internship in Surgery (General Surgery) at Penn State Milton S Hershey Medical Center

    08/01/1994 - 05/01/1995
    Graduate at Rutgers-The State University Of New Jersey School Of Engineering

    08/01/1990 - 05/01/1994
    Graduate at Rutgers-The State University Of New Jersey School Of Engineering

    VIEW ALL expand_more

    Awards

    2004
    John Waldhausen Fellowship Award for Research
    Location: Pennsylvania State University, Hershey, PA

    2004
    American Physiological Society Research Recognition Award for Outstanding Abstract Presentation

    2004
    Pennsylvania Society of Colon and Rectal Surgeons Research Presentation Award

    VIEW ALL expand_more

    Clinical Trials

    Melanoma Margins Trial-II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (02.18 MelMarT-II)

    Lead Researcher: Eva Galka

    Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.

    View Study Details

    Publications

    Journal Articles

    1/25/2022
    Burchard PR, Dave YA, Loria AP, Parikh NB, Pineda-Solis K, Ruffolo LI, Strawderman M, Schoeniger LO, Galka E, Tomiyama K, Orloff MS, Carpizo DR, Linehan DC, Hernandez-Alejandro R. "Early postoperative ERAS compliance predicts decreased length of stay and complications following liver resection." HPB : the official journal of the International Hepato Pancreato Biliary Association.. 2022 Jan 25; Epub 2022 Jan 25.

    12/1/2018
    Mercurio MG, Galka E, Soh JM. "Herpetic Whitlow-A Case of Inadvertent Inoculation With Melanoma Viral Therapy." JAMA dermatology.. 2018 Dec 1; 154(12):1487-1488.

    6/2015
    Linehan D, Galka E. "Lingering Questions on Choledochal Cysts." JAMA surgery.. 2015 Jun; 150(6):584.

    VIEW ALL PUBLICATIONS

    Reviews

    At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information.